Recruiting
Phase 2

Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation

Sponsor:

Meshalkin Research Institute of Pathology of Circulation

Code:

NCT02008448

Conditions

Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Pulmonary vein isolation

Linear Lesion Ablation

BT injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information